Microcystic macular oedema, Thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: A retrospective study

The Lancet Neurology

Volumn 11, Issue 11, 2012, Pages 963-972

  Saidha, Shiv ^a   Sotirchos, Elias S ^a   Ibrahim, Mohamed A ^b   Crainiceanu, Ciprian M ^a   Gelfand, Jeffrey M ^c   Sepah, Yasir J ^b   Ratchford, John N ^a   Oh, Jiwon ^a   Seigo, Michaela A ^a   Newsome, Scott D ^a   Balcer, Laura J ^d   Frohman, Elliot M ^e   Green, Ari J ^c   Nguyen, Quan D ^b   Calabresi, Peter A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING EQUIPMENT; DISEASE ACTIVITY; DISEASE COURSE; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA BIPOLAR GANGLION CELL; RETINA INNER PLEXIFORM LAYER; RETINA MACULA EDEMA; RETROSPECTIVE STUDY; VISION;

ADULT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RETINA; RETINAL GANGLION CELLS; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84867646435     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(12)70213-2     Document Type: Article

References (35)

1. Prineas J Pathology of multiple sclerosis. Handbook of multiple sclerosis 2001, 289-324. Marcel Dekker, New York. S. Cook (Ed.).
2. Calabrese M, Atzori M, Bernardi V, et al. Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol 2007, 254:1212-1220.
3. Calabrese M, Agosta F, Rinaldi F, et al. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 2009, 66:1144-1150.
4. Moll NM, Rietsch AM, Ransohoff AJ, et al. Cortical demyelination in PML and MS: similarities and differences. Neurology 2008, 70:336-343.
5. Saidha S, Syc SB, Ibrahim MA, et al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 2011, 134:518-533.
6. Saidha S, Syc SB, Durbin MK, et al. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler 2011, 17:1449-1463.
7. Kerrison JB, Flynn T, Green WR Retinal pathologic changes in multiple sclerosis. Retina 1994, 14:445-451.
8. Engell T, Hvidberg A, Uhrenholdt A Multiple sclerosis: periphlebitis retinalis et cerebro-spinalis. A correlation between periphlebitis retinalis and abnormal technetium brain scintigraphy. Acta Neurol Scand 1984, 69:293-297.
9. Sepulcre J, Murie-Fernandez M, Salinas-Alaman A, Garcia-Layana A, Bejarano B, Villoslada P Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Neurology 2007, 68:1488-1494.
10. Donaldson MJ, Pulido JS, Herman DC, Diehl N, Hodge D Pars planitis: a 20-year study of incidence, clinical features, and outcomes. Am J Ophthalmol 2007, 144:812-817.
11. Green AJ, McQuaid S, Hauser SL, Allen IV, Lyness R Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain 2010, 133:1591-1601.
12. Saidha S, Eckstein C, Ratchford JN Optical coherence tomography as a marker of axonal damage in multiple sclerosis. CML Multiple Sclerosis 2010, 2:33-43.
13. Shindler KS, Ventura E, Dutt M, Rostami A Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis. Exp Eye Res 2008, 87:208-213.
14. Talman LS, Bisker ER, Sackel DJ, et al. Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol 2010, 67:749-760.
15. Brandt AU, Oberwahrenbrock T, Ringelstein M, et al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 2011, 134:e193.
16. Forooghian F, Sproule M, Westall C, et al. Electroretinographic abnormalities in multiple sclerosis: possible role for retinal autoantibodies. Doc Ophthalmol 2006, 113:123-132.
17. Gundogan FC, Demirkaya S, Sobaci G Is optical coherence tomography really a new biomarker candidate in multiple sclerosis?-A structural and functional evaluation. Invest Ophthalmol Vis Sci 2007, 48:5773-5781.
18. Levkovitch-Verbin H, Quigley HA, Kerrigan-Baumrind LA, D'Anna SA, Kerrigan D, Pease ME Optic nerve transection in monkeys may result in secondary degeneration of retinal ganglion cells. Invest Ophthalmol Vis Sci 2001, 42:975-982.
19. Gelfand JM, Nolan R, Schwartz DM, Graves J, Green AJ Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain 2012, 135:1786-1793.
20. Saidha S, Sotirchos ES, Oh S, et al. Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. Arch Neurol 2012, published online Oct 1. 10.1001/archneurol.2013.57.
21. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011, 69:292-302.
22. Hume DA, Perry VH, Gordon S Immunohistochemical localization of a macrophage-specific antigen in developing mouse retina: phagocytosis of dying neurons and differentiation of microglial cells to form a regular array in the plexiform layers. J Cell Biol 1983, 97:253-257.
23. Srivastava R, Aslam M, Kalluri SR, et al. Potassium channel KIR4.1 as an immune target in multiple sclerosis. N Engl J Med 2012, 367:115-123.
24. Reichenbach A, Wurm A, Pannicke T, Iandiev I, Wiedemann P, Bringmann A Müller cells as players in retinal degeneration and edema. Graefes Arch Clin Exp Ophthalmol 2007, 245:627-636.
25. Brar M, Yuson R, Kozak I, et al. Correlation between morphologic features on spectral-domain optical coherence tomography and angiographic leakage patterns in macular edema. Retina 2010, 30:383-389.
26. Rucker CW Sheathing of the retinal veins in multiple sclerosis. review of pertinent literature. Mayo Clin Proc 1972, 47:335-340.
27. Cohen JA, Barkhof F, Comi G, et al. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med 2010, 362:402-415.
28. Lightman S, McDonald WI, Bird AC, et al. Retinal venous sheathing in optic neuritis. Its significance for the pathogenesis of multiple sclerosis. Brain 1987, 110:405-414.
29. Gills JP, Wadsworth JA Degeneration of the inner nuclear layer of the retina following lesions of the optic nerve. Trans Am Ophthalmol Soc 1966, 64:66-88.
30. Marrie RA, Horwitz RI Emerging effects of comorbidities on multiple sclerosis. Lancet Neurol 2010, 9:820-828.
31. Syc SB, Saidha S, Newsome SD, et al. Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain 2012, 135:521-533.
32. Seigo MA, Sotirchos ES, Newsome S, et al. In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques. J Neurol 2012, published online March 15. 10.1007/s00415-012-6466-x.
33. Walter SD, Ishikawa H, Galetta KM, et al. Ganglion cell loss in relation to visual disability in multiple sclerosis. Ophthalmology 2012, 119:1250-1257.
34. Albrecht P, Ringelstein M, Mueller A, et al. Degeneration of retinal layers in multiple sclerosis subtypes quantified by optical coherence tomography. Mult Scler 2012, published online March 2. 10.1177/1352458512439237.
35. Sriram P, Graham SL, Wang C, Yiannikas C, Garrick R, Klistorner A Transsynaptic retinal degeneration in optic neuropathies: optical coherence tomography study. Invest Ophthalmol Vis Sci 2012, 53:1271-1275.